Macquarie Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Hold |
230,000
| – | – | ﹤0.01% | 1278 |
|
|
2025
Q1 | $1.38M | Hold |
230,000
| – | – | ﹤0.01% | 1329 |
|
|
2024
Q4 | $1.79M | Hold |
230,000
| – | – | ﹤0.01% | 1231 |
|
|
2024
Q3 | $2.48M | Hold |
230,000
| – | – | ﹤0.01% | 1166 |
|
|
2024
Q2 | $1.94M | Hold |
230,000
| – | – | ﹤0.01% | 1232 |
|
|
2024
Q1 | $1.55M | Hold |
230,000
| – | – | ﹤0.01% | 1293 |
|
|
2023
Q4 | $1.35M | Hold |
230,000
| – | – | ﹤0.01% | 1313 |
|
|
2023
Q3 | $2.24M | Hold |
230,000
| – | – | ﹤0.01% | 1133 |
|
|
2023
Q2 | $2.72M | Hold |
230,000
| – | – | ﹤0.01% | 1083 |
|
|
2023
Q1 | $2.48M | Hold |
230,000
| – | – | ﹤0.01% | 1102 |
|
|
2022
Q4 | $2.66M | Hold |
230,000
| – | – | ﹤0.01% | 1124 |
|
|
2022
Q3 | $3.43M | Hold |
230,000
| – | – | ﹤0.01% | 1083 |
|
|
2022
Q2 | $2.08M | Buy |
+230,000
| New | +$2.08M | ﹤0.01% | 1286 |
|